In the current study, the motion pattern of tumor-associated immune cells was monitored as a functional response to PD-1 and CTLA-4 pathways to elucidate, at the cell-level temporal resolution, the kinetic constraints that potentially modulate the response to checkpoint blockade. The gene discussed is PDCD1; the disease is neoplasm.